IMM01
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for IMM01, covering 2023-04-27 to 2025-11-25. Get the full timeline:
Most recent: Clinical Trial Update: IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2) [Phase 3]